Fremanezumab in the treatment of migraines: evidence to date

Robblee, J; VanderPluym, J

VanderPluym, J (reprint author), Mayo Clin, Dept Neurol, 13400 E Shea Blvd, Scottsdale, AZ 85259 USA.

JOURNAL OF PAIN RESEARCH, 2019; 12 (): 2589

Abstract

Calcitonin gene-related peptide (CGRP) is a major player in migraine pathophysiology, and CGRP monoclonal antibodies including fremanezumab may be a s......

Full Text Link